Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)Jeffrey S. Weber, Georgina V. Long, Victoria Atkinson et al.|Journal of Clinical Oncology|2022Cited by 166
Abstract CT004: Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915)Georgina V. Long, Jeffrey S. Weber, Dirk Schadendorf et al.|Cancer Research|2021Cited by 36